The global fertility services market is anticipated to reach USD 70.27 billion by 2030 and is projected to grow at a CAGR of 7.50% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of fertility services, especially among individuals facing issues such as old age, premature ovarian failure, and rising infertility in male and female, is a major driver propelling market growth.
IVF services are particularly popular among individuals aged between 35 and 39 years, driving demand for fertility services. Furthermore, the global fertility rate is falling steadily due to several issues, including the growing trend of delayed marriages and the increasing incidence of age-related infertility. According to the UN's World Family Planning 2022 report, the global fertility rate decreased from 3.3 children per woman in 1990 to 2.3 in 2021. This decreasing fertility rate has significantly increased the demand for male and female ART. In addition, supportive government funding for expensive ART procedures is expected to drive market growth.
In India, the government offers incentives, such as low-interest loans to establish hospitals, subsidies to buy medicines & equipment, and buying lands for clinics. To capitalize on low costs, the Indian government issues M (medical) visas to foreign tourists and MX visas for spouses, valid for a year. For instance, in May 2022, in Australia, under NSW Government 2022–2023 budget, women in New South Wales opting for IVF will be provided with a USD 2,000 cash rebate to reduce the treatment costs for patients. The demand for frozen nondonor IVF treatment is projected to increase significantly. This can be attributed to the large number of procedures performed using frozen nondonor (patient’s eggs).
Request a free sample copy or view report summary: Fertility Services Market Report
Based on type, the treatment segment held the market with the largest revenue share of 65.33% in 2023. The treatment segment is further segmented into In-vitro fertilization (IVF) and artificial insemination. In 2023, IVF treatment dominated the market growth
Improved outcomes of infertility treatments has led to positive awareness regarding fertility services. Favorable reimbursement policies, increasing disposable income, and availability of fertility treatments are also driving growth
Based on provider, the fertility clinics segment held market with the largest revenue share of 80.02% in 2023, owing to the advancements in fertility clinics and the adoption of new technologies
Europe dominated the market with the revenue share of 35.74% in 2023, due to increased investments from private equity investors in the European market, providing lucrative opportunities for market growth
In May 2023, Genea Biomedx partnered with AIVF to offer an integrated solution for personalized and optimized IVF care
In October 2022, the startup Alife launched AI technology to advance IVF treatment outcomes and lower costs
Grand View Research has segmented the global fertility services market report based on type, provider, and region:
Fertility Services Type Outlook (Revenue, USD Million, 2018 - 2030)
Diagnosis
Male Infertility
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Others
Female Infertility
Ovarian reserve testing
Hysterosalpingography
Hormone testing
Other Tests
Treatment
In-Vitro Fertilization (IVF)
Artificial Insemination
Preservation
Egg & Embryo Freezing
Sperm Banking
Fertility Services Provider Outlook (Revenue, USD Million, 2018 - 2030)
Fertility Clinics
Hospitals and Others
Fertility Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Fertility Services Market
PFCLA
Mayo Foundation for Medical Education and Research (MFMER)
Cleveland Clinic
Apricity Fertility UK Limited
King’s Fertility Limited
Dallas IVF
Midwest Fertility Specialists
Europe IVF
Care Fertility
Aspire Fertility
Virtus Health
Monash IVF Group
"The quality of research they have done for us has been excellent..."